Alzheimer's Disease Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

Alzheimer's Disease Trends and Forecast

The future of the global alzheimer's disease diagnostic market looks promising with opportunities in the clinic, hospital, diagnostic center, pharmaceutical company, and academic research center markets. The global alzheimer's disease diagnostic market is expected to reach an estimated $5.4 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of alzheimer's disease, rising demand for early diagnosis, and rapid advancement in healthcare technology.

A more than 150-page report is developed to help in your business decisions.

Alzheimer's Disease by Segment

The study includes a forecast for the global alzheimer's disease by type, end use, and region.

Alzheimer's Disease Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Nervous System
• Examination
• Genetic Testing
• Minor Mental State Examination
• Brain Imaging Tests

Alzheimer's Disease Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Clinics
• Hospitals
• Diagnostic Centers
• Pharmaceutical Companies
• Academic Research Centers

Alzheimer's Disease Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Alzheimer's Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies alzheimer's disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the alzheimer's disease companies profiled in this report include-

• AbbVie
• AC Immune
• Amarantus Bioscience
• Anavex Life Sciences
• Eli Lilly And Company
• AXON Neuroscience
• Sio Gene Therapies

Alzheimer's Disease Diagnostic Market Insights

Lucintel forecasts that brain imaging test is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to high prevalence of alzheimer's disease and rapid adoption of new diagnostic technologies in the region.

Features of the Global Alzheimer's Disease Diagnostic Market

Market Size Estimates: Alzheimer's disease diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Alzheimer's disease diagnostic market size by type, end use, and region in terms of value ($B).

Regional Analysis: Alzheimer's disease diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the alzheimer's disease diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the alzheimer's disease diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the alzheimer's disease diagnostic market size?

Answer: The global alzheimer's disease diagnostic market is expected to reach an estimated $5.4 billion by 2030.

Q.2 What is the growth forecast for alzheimer's disease diagnostic market?

Answer: The global alzheimer's disease diagnostic market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the alzheimer's disease diagnostic market?

Answer: The major drivers for this market are increasing prevalence of alzheimer's disease, rising demand for early diagnosis, and rapid advancement in healthcare technology.

Q4. What are the major segments for alzheimer's disease diagnostic market?

Answer: The future of the alzheimer's disease diagnostic market looks promising with opportunities in the clinic, hospital, diagnostic center, pharmaceutical company, and academic research center markets.

Q5. Who are the key alzheimer's disease diagnostic market companies?

Answer: Some of the key alzheimer's disease companies are as follows:

• AbbVie
• AC Immune
• Amarantus Bioscience
• Anavex Life Sciences
• Eli Lilly And Company
• AXON Neuroscience
• Sio Gene Therapies

Q6. Which alzheimer's disease diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that brain imaging test is expected to witness highest growth over the forecast period.

Q7. In alzheimer's disease diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of alzheimer's disease and rapid adoption of new diagnostic technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the alzheimer's disease diagnostic market by type (nervous system, examination, genetic testing, minor mental state examination, and brain imaging tests), end use (clinics, hospitals, diagnostic centers, pharmaceutical companies, and academic research centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?